seribantumab
elevation oncology
['seribantumab']
#asco22 while #nrg1 fusions are rare, when present, standard therapy like chemotherapy and immunotherapy seems to be less effective and these data with seribantumab show that nrg1 fusions can be successfully targeted. again - if ngs used is dna-based, likely to miss nrg1. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him